Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds B of A Securities Downgrades Coupang to Neutral

B of A Securities Downgrades Coupang to Neutral

B of A Securities analyst Susie Lee downgrades Coupang (NYSE:CPNG) from Buy to Neutral.

byBenzinga Newsdesk

March 2, 2023

1 minute read

B of A Securities analyst Susie Lee downgrades Coupang (NYSE:CPNG) from Buy to Neutral.

Iridium Sets Positive 2024 Outlook, Eyes Revenue Growth, Rising Subscriber Numbers

By Anusuya Lahiri

February 15, 12:26 PM

Iridium reported flat fourth-quarter FY23 revenue growth to $194.74 million, beating the consensus of $194.03 million.

IRDM

Chart Industries Shares Soar As Q2 Results Surpass Expectations

By Akanksha Bakshi

July 29, 12:11 PM

Chart Industries, Inc. (NYSE:GTLS) reported second-quarter FY22 sales growth of 25.7% year-over-year to $404.8 million, beating the consensus of $390.49…

GTLS

IDEAYA Announces Clinical Trial Collaboration with Amgen to Evaluate MAT2A-PRMT5 Synthetic Lethality Combination in MTAP Deleted Tumors

By Charles Gross

July 27, 6:05 AM

IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a synthetic lethality focused precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced it has entered into a clinical trial collaboration and supply agreement with Amgen Inc.

AMGN